Bank of America
BRTX icon

Bank of America’s BioRestorative Therapies BRTX Stock Holding History

Bank of America’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60
Closed -$71 – 5868
2025
Q4 		$71 Buy
60
+10
+20% +$13 ﹤0.01% 6892
2025
Q3 		$73 Hold
50
– – ﹤0.01% 7920
2025
Q2 		$83 Buy
50
+7
+16% +$12 ﹤0.01% 7999
2025
Q1 		$77 Buy
43
+1
+2% +$2 ﹤0.01% 7888
2024
Q4 		$60 Hold
42
– – ﹤0.01% 7837
2024
Q3 		$73 Sell
42
-5
-11% -$8 ﹤0.01% 7770
2024
Q2 		$95 Buy
+47
New +$68 ﹤0.01% 7711
2024
Q1 		– Sell
-54
Closed -$94 – 7753
2023
Q4 		$94 Buy
+54
New +$103 ﹤0.01% 7423
2023
Q1 		– Sell
-6
Closed -$16 – 7826
2022
Q4 		$16 Buy
+6
New +$19 ﹤0.01% 8013

Other funds holding BRTX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America's BRTX Position: Q1 2026 in Review

Bank of America sold out of BioRestorative Therapies (BRTX) in Q1 2026, closing a stake of 60 shares — an estimated $71 sold.

Bank of America first reported a position in BRTX in Q4 2022 and held it in 9 quarters. The position peaked at $95 in Q2 2024. 11 funds tracked by Wall St. Rank hold BRTX as of Q1 2026.

  • Bank of America reported no remaining BioRestorative Therapies position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 60 BioRestorative Therapies shares in Q1 2026, an estimated $71.
  • Bank of America first reported a position in BioRestorative Therapies in Q4 2022 and held it in 9 quarters.
  • Bank of America's BioRestorative Therapies position peaked at $95 in Q2 2024.
  • 11 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.